Maoxiang Qian
Overview
Explore the profile of Maoxiang Qian including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
53
Citations
1065
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Single cell immunoprofile of synovial fluid in rheumatoid arthritis with TNF/JAK inhibitor treatment
Xia X, He C, Xue Z, Wang Y, Qin Y, Ren Z, et al.
Nat Commun
. 2025 Mar;
16(1):2152.
PMID: 40038288
Numerous patients with rheumatoid arthritis (RA) manifest severe syndromes, including elevated synovial fluid volumes (SF) with abundant immune cells, which can be controlled by TNF/JAK inhibitors. Here, we apply single-cell...
2.
Jia R, Li Z, Hu S, Chang H, Zeng M, Liu P, et al.
Front Immunol
. 2024 Aug;
15:1358725.
PMID: 39148728
Introduction: The immunological characteristics that could protect children with coronavirus disease 2019 (COVID-19) from severe or fatal illnesses have not been fully understood yet. Methods: Here, we performed single-cell RNA...
3.
Yang J, Zhu X, Zhang H, Fu Y, Li Z, Xing Z, et al.
Hematology
. 2024 Jul;
29(1):2381169.
PMID: 39046131
Background: Acute myeloid leukemia (AML) with t(8;21) manifests as a diverse hematological malignancy. Although it was categorized into a favorable subtype, 30-40% of patients experience relapse. The objective of this...
4.
Gao H, Huang X, Chen W, Feng Z, Zhao Z, Li P, et al.
Chin Med J (Engl)
. 2024 Jul;
137(15):1823-1834.
PMID: 38973237
Background: Heterotaxy (HTX) is a thoracoabdominal organ anomaly syndrome and commonly accompanied by congenital heart disease (CHD). The aim of this study was to analyze rare copy number variations (CNVs)...
5.
Diedrich J, Dong Q, Ferguson D, Bergeron B, Autry R, Qian M, et al.
Leukemia
. 2024 Jul;
38(8):1867.
PMID: 38961139
No abstract available.
6.
Mao W, Zhou T, Zhang F, Qian M, Xie J, Li Z, et al.
Pharmacogenet Genomics
. 2024 May;
34(7):217-225.
PMID: 38814173
Objective: Varied expression of drug-metabolizing enzymes (DME) genes dictates the intensity and duration of drug response in cancer treatment. This study aimed to investigate the transcriptional profile of DMEs in...
7.
Zhang H, Wan Y, Wang H, Cai J, Yu J, Hu S, et al.
Cancer
. 2023 Mar;
129(11):1691-1703.
PMID: 36943767
Background: Contemporary risk-directed treatment has improved the outcome of patients with acute lymphoblastic leukemia (ALL) and TCF3::PBX1 fusion. In this study, the authors seek to identify prognostic factors that can...
8.
Liu S, Xiang Y, Wang B, Gao C, Chen Z, Xie S, et al.
Blood Adv
. 2023 Mar;
7(13):3099-3112.
PMID: 36912760
The effect of aerobic glycolysis remains elusive in pediatric T-cell acute lymphoblastic leukemia (T-ALL). Increasing evidence has revealed that dysregulation of deubiquitination is involved in glycolysis, by targeting glycolytic rate-limiting...
9.
Zhu Y, Tan Y, Li L, Xiang Y, Huang Y, Zhang X, et al.
Nucleic Acids Res
. 2023 Jan;
51(6):e32.
PMID: 36715337
Protein-DNA damage interactions are critical for understanding the mechanism of DNA repair and damage response. However, due to the relatively random distributions of UV-induced damage and other DNA bulky adducts,...
10.
Chu X, Qian M, Yang J, Wu D, Gao J, Cao L, et al.
Front Pediatr
. 2023 Jan;
10:1044866.
PMID: 36714653
Purpose: To evaluate the influence of rs3824662 on pre-B-cell acute lymphoblastic leukemia (pre-B-cell ALL) susceptibility and long-term prognosis in Han Chinese children with pre-B-cell ALL treated with the CCLG-2008 protocol...